Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jo Lewis

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Journal of Microbiology and Biotechnology|March 27, 2025
A Meta-Analysis on the Immunogenicity of Homologous versus Heterologous Immunization Regimens against SARS-CoV-2 Beta, Delta, and Omicron BA.1 VoCs in Healthy AdultsJo-Lewis Banga Ndzouboukou, Abdul A Kamara, Nadeem Ullah, et al.
Respiratory Medicine|November 26, 2003
Topical tetracaine prior to arterial puncture: a randomized, placebo-controlled clinical trialShawn D Aaron, Katherine L Vandemheen, Sheila A Naftel, et al.
International Journal of Nursing Practice|March 15, 2006
Ineffectiveness of the measurement of 'routine' vital signs for adult inpatients with community-acquired pneumoniaPaul Mariani, Musab U Saeed, Anil Potti, et al.
Journal of Immunology Research|September 21, 2020
Differential Immunogenicity and Protective Efficacy Elicited by MTO- and DMT-Adjuvanted CMFO Subunit Vaccines against <i>Mycobacterium tuberculosis</i> InfectionNadeem Ullah, Ling Hao, Yaqi Wu, et al.
Appetite|April 17, 2022
A comparative transcriptomic analysis of glucagon-like peptide-1 receptor- and glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamusChristopher Smith, Ryan Patterson-Cross, Orla Woodward, et al.
Frontiers in Immunology|October 29, 2020
Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit VaccineLing Hao, Yaqi Wu, Yandi Zhang, et al.
Pathogens (Basel, Switzerland)|June 2, 2021
Label-Free Comparative Proteomics of Differentially Expressed <i>Mycobacterium tuberculosis</i> Protein in Rifampicin-Related Drug-Resistant StrainsNadeem Ullah, Ling Hao, Jo-Lewis Banga Ndzouboukou, et al.
Theranostics|September 15, 2020
Enhanced tuberculosis clearance through the combination treatment with recombinant adenovirus-mediated granulysin deliveryLing Hao, Jilei Ma, Chunwei Shi, et al.
Current Medical Science|November 6, 2021
Human IgM and IgG Responses to an Inactivated SARS-CoV-2 VaccineJo-Lewis Banga Ndzouboukou, Yan-di Zhang, Qing Lei, et al.
Journal of Immunology Research|October 29, 2021
Kinetics of Neutralizing Antibody Response Underscores Clinical COVID-19 ProgressionQing Lei, Hongyan Hou, Caizheng Yu, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Journal of Microbiology and Biotechnology|March 27, 2025
A Meta-Analysis on the Immunogenicity of Homologous versus Heterologous Immunization Regimens against SARS-CoV-2 Beta, Delta, and Omicron BA.1 VoCs in Healthy AdultsJo-Lewis Banga Ndzouboukou, Abdul A Kamara, Nadeem Ullah, et al.
Respiratory Medicine|November 26, 2003
Topical tetracaine prior to arterial puncture: a randomized, placebo-controlled clinical trialShawn D Aaron, Katherine L Vandemheen, Sheila A Naftel, et al.
International Journal of Nursing Practice|March 15, 2006
Ineffectiveness of the measurement of 'routine' vital signs for adult inpatients with community-acquired pneumoniaPaul Mariani, Musab U Saeed, Anil Potti, et al.
Journal of Immunology Research|September 21, 2020
Differential Immunogenicity and Protective Efficacy Elicited by MTO- and DMT-Adjuvanted CMFO Subunit Vaccines against <i>Mycobacterium tuberculosis</i> InfectionNadeem Ullah, Ling Hao, Yaqi Wu, et al.
Appetite|April 17, 2022
A comparative transcriptomic analysis of glucagon-like peptide-1 receptor- and glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamusChristopher Smith, Ryan Patterson-Cross, Orla Woodward, et al.
Frontiers in Immunology|October 29, 2020
Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit VaccineLing Hao, Yaqi Wu, Yandi Zhang, et al.
Pathogens (Basel, Switzerland)|June 2, 2021
Label-Free Comparative Proteomics of Differentially Expressed <i>Mycobacterium tuberculosis</i> Protein in Rifampicin-Related Drug-Resistant StrainsNadeem Ullah, Ling Hao, Jo-Lewis Banga Ndzouboukou, et al.
Theranostics|September 15, 2020
Enhanced tuberculosis clearance through the combination treatment with recombinant adenovirus-mediated granulysin deliveryLing Hao, Jilei Ma, Chunwei Shi, et al.
Current Medical Science|November 6, 2021
Human IgM and IgG Responses to an Inactivated SARS-CoV-2 VaccineJo-Lewis Banga Ndzouboukou, Yan-di Zhang, Qing Lei, et al.
Journal of Immunology Research|October 29, 2021
Kinetics of Neutralizing Antibody Response Underscores Clinical COVID-19 ProgressionQing Lei, Hongyan Hou, Caizheng Yu, et al.
Pageof 4